Concentric Analgesics

About

Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.

San Francisco,California,United States
11 - 50

Highlights

Details

Last Funding Type: Convertable Note
Last Funding Money Raised: $20M
Industries: Biotechnology,Health Care,Medical,Medical Device
Founded date: Jan 1, 2014
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Concentric Analgesics, Inc.

Concentric Analgesics is developing a portfolio of novel, non-opioid therapeutics that provide pain relief after a single local administration. It is a biotechnology company focused on developing non-opioid therapeutics for the management of acute and chronic pain.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$103.07M

Concentric Analgesics has raised a total of $103.07M in funding over 2 rounds. Their latest funding was raised on Jan 26, 2022 from a Convertable Note round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 26, 2022	Convertable Note	$20M	—	—	—	Detail
May 22, 2019	Series B	$77.10M	3	Oracle Investment Management Inc.	—	Detail
Aug 17, 2016	Series Unknown	$5.97M	—	—	—	Detail